Abstract
In article number 2004377, Ke Cheng, Xiaojie Wang, and co-workers fabricate a fibroblast growth factor (FGF)-loaded and reactive oxygen species (ROS)-responsive hydrogel for intrapericardial delivery. The safety and feasibility of minimally invasive injection and access into the pericardial cavity in both pigs and human patients are also demonstrated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
